• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

50 岁以下男性手术时前列腺根治性切除术标本的组织病理学结果:对前列腺癌筛查计划可能的影响?

Histopathological results of radical prostatectomy specimen of men younger than 50 years of age at the time of surgery: possible implications for prostate cancer screening programs?

机构信息

Martini-Clinic, Prostate Cancer Center Hamburg-Eppendorf, Martinistr. 52, 20246, Hamburg, Germany.

Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.

出版信息

World J Urol. 2023 Feb;41(2):421-425. doi: 10.1007/s00345-023-04287-1. Epub 2023 Jan 19.

DOI:10.1007/s00345-023-04287-1
PMID:36656332
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9947052/
Abstract

INTRODUCTION

Prostate cancer (PCa) detection is usually achieved by PSA measurement and, if indicated, further diagnostics. The recent EAU guidelines recommend a first PSA test at the age of 50 years, if no family history of PCa or BRCA2 mutation exists. However, some men might harbor significant PCa at younger age; thus we evaluated the histopathological results of men treated with radical prostatectomy (RP) in their 40 s at our institution.

MATERIALS AND METHODS

We relied on the data of all patients who underwent RP in our institution between 1992 and 2020 and were younger than 50 years at the time of surgery. The histopathological results are descriptively presented. Moreover, we tested the effect of a positive family history on the descriptive results.

RESULTS

Overall, 1225 patients younger than 50 years underwent RP at our institution. Median age was 47 years. Most patients showed favorable histopathological characteristics. However, 20% of patients had extraprostatic disease (≥ pT3a), 15% had ISUP Gleason grade group ≥ 3, and 7% had positive lymph nodes (pN1). Patients with a known positive family history did not have a higher rate of adverse disease as their counterparts with a negative family history.

DISCUSSION

Our data show that the majority of patients who were diagnosed with PCa at a very young age had favorable histopathological RP characteristics. However, a non-negligible proportion of patients already showed locally advanced disease and would have probably benefited from earlier PCa detection. This should be kept in mind when PCa screening recommendations are proposed.

摘要

简介

前列腺癌(PCa)的检测通常通过 PSA 测量来实现,如果需要,进一步进行诊断。最近的 EAU 指南建议,如果没有 PCa 家族史或 BRCA2 突变,在 50 岁时进行首次 PSA 检测。然而,一些男性可能在年轻时就患有显著的 PCa;因此,我们评估了在我们机构接受根治性前列腺切除术(RP)治疗的 40 多岁男性的组织病理学结果。

材料和方法

我们依赖于在我们机构接受 RP 治疗且在手术时年龄小于 50 岁的所有患者的数据。描述性地呈现了组织病理学结果。此外,我们还测试了阳性家族史对描述性结果的影响。

结果

总体而言,我们机构有 1225 名年龄小于 50 岁的患者接受了 RP。中位年龄为 47 岁。大多数患者具有良好的组织病理学特征。然而,20%的患者有前列腺外疾病(≥ pT3a),15%的患者有 ISUP 分级组≥3,7%的患者有阳性淋巴结(pN1)。有明确阳性家族史的患者与阴性家族史的患者相比,其不良疾病的发生率并没有更高。

讨论

我们的数据表明,大多数在非常年轻时被诊断出患有 PCa 的患者具有良好的组织病理学 RP 特征。然而,相当一部分患者已经出现局部晚期疾病,可能会受益于更早的 PCa 检测。在提出 PCa 筛查建议时,应牢记这一点。

相似文献

1
Histopathological results of radical prostatectomy specimen of men younger than 50 years of age at the time of surgery: possible implications for prostate cancer screening programs?50 岁以下男性手术时前列腺根治性切除术标本的组织病理学结果:对前列腺癌筛查计划可能的影响?
World J Urol. 2023 Feb;41(2):421-425. doi: 10.1007/s00345-023-04287-1. Epub 2023 Jan 19.
2
Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.根治性前列腺切除术是治疗标本中存在高病理 Gleason 评分前列腺癌的有效方法。
BJU Int. 2013 May;111(5):723-30. doi: 10.1111/j.1464-410X.2012.11114.x. Epub 2012 Apr 4.
3
The increase of stage, grading, and metastases in patients undergoing radical prostatectomy during the last decade.在过去十年中,接受根治性前列腺切除术的患者的分期、分级和转移增加。
World J Urol. 2019 Jun;37(6):1103-1109. doi: 10.1007/s00345-018-2487-0. Epub 2018 Sep 17.
4
[Functional and oncological outcome of salvage prostatectomy of locally recurrent prostate cancer following radiation therapy].[放射治疗后局部复发性前列腺癌挽救性前列腺切除术的功能和肿瘤学结果]
Urologe A. 2006 Apr;45(4):474-81. doi: 10.1007/s00120-006-0995-9.
5
Tertiary Gleason pattern in radical prostatectomy specimens is associated with worse outcomes than the next higher Gleason score group in localized prostate cancer.在局限性前列腺癌中,根治性前列腺切除术标本中的三级Gleason分级模式与下一个更高Gleason评分组相比,预后更差。
Urol Oncol. 2018 Apr;36(4):158.e1-158.e6. doi: 10.1016/j.urolonc.2017.12.003. Epub 2017 Dec 27.
6
The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.根治性前列腺切除术后前列腺特异性抗原持续存在对预测淋巴结阳性前列腺癌患者临床进展和癌症特异性死亡率的作用。
Eur Urol. 2016 Jun;69(6):1142-8. doi: 10.1016/j.eururo.2015.12.010. Epub 2015 Dec 31.
7
Pathological stage distribution in patients treated with radical prostatectomy reflecting the need for protocol-based active surveillance: results from a contemporary European patient cohort.根治性前列腺切除术治疗患者的病理分期分布反映了基于方案的主动监测的必要性:来自当代欧洲患者队列的结果。
BJU Int. 2012 Jul;110(2):195-200. doi: 10.1111/j.1464-410X.2011.10707.x. Epub 2011 Nov 17.
8
Prostate-specific antigen density predicts extracapsular extension and increased risk of biochemical recurrence in patients with high-risk prostate cancer who underwent radical prostatectomy.前列腺特异性抗原密度可预测接受根治性前列腺切除术的高危前列腺癌患者的包膜外侵犯及生化复发风险增加。
Int J Clin Oncol. 2015 Feb;20(1):176-81. doi: 10.1007/s10147-014-0696-0. Epub 2014 Apr 29.
9
Identifying the best candidate for radical prostatectomy among patients with high-risk prostate cancer.在高危前列腺癌患者中确定接受根治性前列腺切除术的最佳人选。
Eur Urol. 2012 Mar;61(3):584-92. doi: 10.1016/j.eururo.2011.11.043. Epub 2011 Dec 2.
10
EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.EAU 前列腺癌指南。第二部分:晚期、复发性和去势抵抗性前列腺癌的治疗。
Eur Urol. 2014 Feb;65(2):467-79. doi: 10.1016/j.eururo.2013.11.002. Epub 2013 Nov 12.

引用本文的文献

1
Adverse In-Hospital Outcomes Following Robot-Assisted vs. Open Radical Prostatectomy in Quadragenarians.四十多岁患者接受机器人辅助与开放性根治性前列腺切除术后的院内不良结局
Cancers (Basel). 2025 Mar 31;17(7):1193. doi: 10.3390/cancers17071193.
2
Tumor characteristics, treatments, and oncological outcomes of prostate cancer in men aged ≤60 years: real-world data from a single urological center over a 10-year period.60岁及以下男性前列腺癌的肿瘤特征、治疗方法及肿瘤学结局:来自单一泌尿外科中心10年期间的真实世界数据。
Transl Androl Urol. 2024 Nov 30;13(11):2408-2418. doi: 10.21037/tau-24-410. Epub 2024 Nov 25.
3
Letter to the editor for the article "Histopathological results of radical prostatectomy specimen of men younger than 50 years of age at the time of surgery: possible implications for prostate cancer screening programs?".

本文引用的文献

1
Impact of family history on clinicopathological variables and disease progression in Japanese prostate cancer patients undergoing robotic-assisted radical prostatectomy.家族史对接受机器人辅助根治性前列腺切除术的日本前列腺癌患者的临床病理变量和疾病进展的影响。
Int J Urol. 2022 Nov;29(11):1339-1346. doi: 10.1111/iju.14990. Epub 2022 Aug 24.
2
A randomized trial of risk-adapted screening for prostate cancer in young men-Results of the first screening round of the PROBASE trial.一项针对年轻男性前列腺癌风险适应筛查的随机试验-PROBASE 试验第一轮筛查结果。
Int J Cancer. 2022 Jun 1;150(11):1861-1869. doi: 10.1002/ijc.33940. Epub 2022 Feb 17.
3
致编辑的信:关于文章《手术时年龄小于50岁男性根治性前列腺切除术标本的组织病理学结果:对前列腺癌筛查项目有何潜在影响?》
World J Urol. 2023 May;41(5):1469-1470. doi: 10.1007/s00345-023-04373-4. Epub 2023 Mar 27.
EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.
EAU-EANM-ESTRO-ESUR-SIOG 前列腺癌指南-2020 版更新。第 1 部分:筛查、诊断和以治愈为目的的局部治疗。
Eur Urol. 2021 Feb;79(2):243-262. doi: 10.1016/j.eururo.2020.09.042. Epub 2020 Nov 7.
4
MRI-Targeted Biopsy for Prostate-Cancer Diagnosis.用于前列腺癌诊断的MRI靶向活检
N Engl J Med. 2018 Aug 9;379(6):589-590. doi: 10.1056/NEJMc1807507.
5
Reevaluating PSA Testing Rates in the PLCO Trial.重新评估前列腺、肺、结直肠癌和卵巢癌筛查试验(PLCO)中的前列腺特异性抗原(PSA)检测率
N Engl J Med. 2016 May 5;374(18):1795-6. doi: 10.1056/NEJMc1515131.
6
Screening for Prostate Cancer Starting at Age 50-54 Years. A Population-based Cohort Study.50 - 54岁开始的前列腺癌筛查。一项基于人群的队列研究。
Eur Urol. 2017 Jan;71(1):46-52. doi: 10.1016/j.eururo.2016.03.026. Epub 2016 Apr 13.
7
Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.前列腺癌筛查与死亡率:欧洲前列腺癌筛查随机研究(ERSPC)13年随访结果
Lancet. 2014 Dec 6;384(9959):2027-35. doi: 10.1016/S0140-6736(14)60525-0. Epub 2014 Aug 6.
8
Functional and oncological outcomes of patients aged <50 years treated with radical prostatectomy for localised prostate cancer in a European population.在欧洲人群中,接受根治性前列腺切除术治疗局限性前列腺癌的<50 岁以下患者的功能和肿瘤学结局。
BJU Int. 2014 Jul;114(1):38-45. doi: 10.1111/bju.12407. Epub 2013 Dec 2.
9
Mortality results from the Göteborg randomised population-based prostate-cancer screening trial.哥德堡随机人群前列腺癌筛查试验的死亡率结果。
Lancet Oncol. 2010 Aug;11(8):725-32. doi: 10.1016/S1470-2045(10)70146-7. Epub 2010 Jul 2.